{"indexed":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T17:10:11Z","timestamp":1566839411111},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00774-015-0687-x","type":"article-journal","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T06:34:04Z","timestamp":1434004444000},"page":"447-456","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":"Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease","prefix":"10.1007","volume":"34","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Polyzois","family":"Makras","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Kokkoris","sequence":"additional","affiliation":[]},{"given":"Grigorios T.","family":"Sakellariou","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,6,9]]},"reference":[{"key":"687_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","volume":"28","author":"M Lazo","year":"2008","unstructured":"Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28:339\u2013350","journal-title":"Semin Liver Dis"},{"key":"687_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"72","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 72:299\u2013314","journal-title":"Curr Mol Med"},{"key":"687_CR3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK (2014) Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59:1174\u20131197","journal-title":"Hepatology"},{"key":"687_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2036.2012.05196.x","volume":"36","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz Y (2012) Review article: non-alcoholic fatty liver disease and osteoporosis-clinical and molecular crosstalk. Aliment Pharmacol Ther 36:345\u2013352","journal-title":"Aliment Pharmacol Ther"},{"key":"687_CR5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.molmed.2013.05.006","volume":"19","author":"G Musso","year":"2013","unstructured":"Musso G, Paschetta E, Gambino R, Cassader M, Molinaro F (2013) Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends Mol Med 19:522\u2013535","journal-title":"Trends Mol Med"},{"key":"687_CR6","first-page":"396545","volume":"2013","author":"R Cui","year":"2013","unstructured":"Cui R, Sheng H, Rui XF, Cheng XY, Sheng CJ, Wang JY, Qu S (2013) Low bone mineral density in chinese adults with nonalcoholic fatty liver disease. Int J Endocrinol 2013:396545","journal-title":"Int J Endocrinol"},{"key":"687_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MED.0b013e32834afff2","volume":"18","author":"AD Anastasilakis","year":"2011","unstructured":"Anastasilakis AD, Polyzos SA, Toulis KA (2011) Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge. Curr Opin Endocrinol Diabetes Obes 18:383\u2013388","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"687_CR8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00774-013-0451-z","volume":"31","author":"HP Bhattoa","year":"2013","unstructured":"Bhattoa HP, Wamwaki J, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P (2013) Serum sclerostin levels in healthy men over 50\u00a0years of age. J Bone Miner Metab 31:579\u2013584","journal-title":"J Bone Miner Metab"},{"key":"687_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of WNT\/\u03b2-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121\u2013132","journal-title":"Calcif Tissue Int"},{"key":"687_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2013.05.010","volume":"56","author":"G Hampson","year":"2013","unstructured":"Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML (2013) The relationship between inhibitors of the Wnt signalling pathway (dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone 56:42\u201347","journal-title":"Bone"},{"key":"687_CR11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1479164113510923","volume":"11","author":"A Gaudio","year":"2014","unstructured":"Gaudio A, Privitera F, Pulvirenti I, Canzonieri E, Rapisarda R, Fiore CE (2014) The relationship between inhibitors of the Wnt signalling pathway (sclerostin and dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Diabetes Vasc Dis Res 11:48\u201352","journal-title":"Diabetes Vasc Dis Res"},{"key":"687_CR12","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/me.2007-0259","volume":"21","author":"SC Manolagas","year":"2007","unstructured":"Manolagas SC, Almeida M (2007) Gone with the Wnts: \u03b2-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol 21:2605\u20132614","journal-title":"Mol Endocrinol"},{"key":"687_CR13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","volume":"315","author":"A Mani","year":"2007","unstructured":"Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315:1278\u20131282","journal-title":"Science"},{"key":"687_CR14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jgh.12106","volume":"28","author":"MM Smits","year":"2013","unstructured":"Smits MM, Ioannou GN, Boyko EJ, Utzschneider KM (2013) Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. J Gastroenterol Hepatol 28:664\u2013670","journal-title":"J Gastroenterol Hepatol"},{"key":"687_CR15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/1354750X.2013.838305","volume":"18","author":"SA Polyzos","year":"2013","unstructured":"Polyzos SA, Kountouras J, Slavakis A, Zafeiriadou E, Patsiaoura K, Katsiki E, Zavos C, Papatheodorou A, Terpos E (2013) A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study. Biomarkers 18:607\u2013613","journal-title":"Biomarkers"},{"key":"687_CR16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van NM, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"687_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"687_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.metabol.2013.10.010","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Mantzoros CS (2014) Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63:161\u2013167","journal-title":"Metabolism"},{"key":"687_CR19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00774-013-0524-z","volume":"32","author":"Y Rhee","year":"2014","unstructured":"Rhee Y, Kim WJ, Han KJ, Lim SK, Kim SH (2014) Effect of liver dysfunction on circulating sclerostin. J Bone Miner Metab 32:542\u2013549","journal-title":"J Bone Miner Metab"},{"key":"687_CR20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/alcalc\/ags136","volume":"48","author":"E Gonz\u00e1lez-Reimers","year":"2013","unstructured":"Gonz\u00e1lez-Reimers E, Mart\u00edn-Gonz\u00e1lez C, de la Vega-Prieto MJ, Pelazas-Gonz\u00e1lez R, Fern\u00e1ndez-Rodr\u00edguez C, L\u00f3pez-Prieto J, Alvisa-Negr\u00edn J, Santolaria-Fern\u00e1ndez F (2013) Serum sclerostin in alcoholics: a pilot study. Alcohol Alcohol 48:278\u2013282","journal-title":"Alcohol Alcohol"},{"key":"687_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.11005\/jbm.2014.21.1.69","volume":"21","author":"E Gonz\u00e1lez-Reimers","year":"2014","unstructured":"Gonz\u00e1lez-Reimers E, L\u00f3pez-Prieto J, Pelazas-Gonz\u00e1lez R, Alem\u00e1n-Valls MR, Jos\u00e9 de la Vega-Prieto M, Jorge-Ripper C, Dur\u00e1n-Castell\u00f3n MC, Santolaria-Fern\u00e1ndez F (2014) Serum sclerostin in hepatitis C virus infected patients. J Bone Metab 21:69\u201375","journal-title":"J Bone Metab"},{"key":"687_CR22","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00198-014-2808-0","volume":"25","author":"R Sapir-Koren","year":"2014","unstructured":"Sapir-Koren R, Livshits G (2014) Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption\u2013formation cycles? Osteoporos Int 25:2685\u20132700","journal-title":"Osteoporos Int"},{"key":"687_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0736-0266(02)00161-4","volume":"21","author":"K Okazaki","year":"2003","unstructured":"Okazaki K, Jingushi S, Ikenoue T, Urabe K, Sakai H, Iwamoto Y (2003) Expression of parathyroid hormone-related peptide and insulin-like growth factor I during rat fracture healing. J Orthop Res 21:511\u2013520","journal-title":"J Orthop Res"},{"key":"687_CR24","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.1152\/ajpendo.00092.2013","volume":"305","author":"KH Lau","year":"2013","unstructured":"Lau KH, Baylink DJ, Zhou XD, Rodriguez D, Bonewald LF, Li Z, Ruffoni D, M\u00fcller R, Kesavan C, Sheng MH (2013) Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity. Am J Physiol Endocrinol Metab 305:E271\u2013E281","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"687_CR25","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jbmr.5650110916","volume":"11","author":"DM Thomas","year":"1996","unstructured":"Thomas DM, Hards DK, Rogers SD, Ng KW, Best JD (1996) Insulin receptor expression in bone. J Bone Miner Res 11:1312\u20131320","journal-title":"J Bone Miner Res"},{"key":"687_CR26","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1210\/jc.2013-1402","volume":"98","author":"AD Anastasilakis","year":"2013","unstructured":"Anastasilakis AD, Polyzos SA, Gkiomisi A, Bisbinas I, Gerou S, Makras P (2013) Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. J Clin Endocrinol Metab 98:3206\u20133212","journal-title":"J Clin Endocrinol Metab"},{"key":"687_CR27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","volume":"46","author":"SA Polyzos","year":"2012","unstructured":"Polyzos SA, Kountouras J, Zavos C, Deretzi G (2012) Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 46:272\u2013284","journal-title":"J Clin Gastroenterol"},{"key":"687_CR28","author":"S Lattanzio","year":"2014","unstructured":"Lattanzio S, Santilli F, Liani R, Vazzana N, Ueland T, Di Fulvio P, Formoso G, Consoli A, Aukrust P, Davi G (2014) Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. J Am Heart Assoc. doi: 10.1161\/JAHA.114.001000","journal-title":"J Am Heart Assoc","DOI":"10.1161\/JAHA.114.001000","doi-asserted-by":"publisher"},{"key":"687_CR29","doi-asserted-by":"crossref","first-page":"e111703","DOI":"10.1371\/journal.pone.0111703","volume":"9","author":"A Garcia-Martin","year":"2014","unstructured":"Garcia-Martin A, Reyes-Garcia R, Garcia-Fontana B, Morales-Santana S, Coto-Montes A, Munoz-Garach M, Rozas-Moreno P, Munoz-Torres M (2014) Relationship of dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus. PLoS One 9:e111703","journal-title":"PLoS One"},{"key":"687_CR30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2009.09.003","volume":"38","author":"JL Freese","year":"2010","unstructured":"Freese JL, Pino D, Pleasure SJ (2010) Wnt signaling in development and disease. Neurobiol Dis 38:148\u2013153","journal-title":"Neurobiol Dis"},{"key":"687_CR31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s13277-014-2750-y","volume":"36","author":"L Liang","year":"2015","unstructured":"Liang L, He H, Lv R, Zhang M, Huang H, An Z, Li S (2015) Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma. Tumour Biol 36:1245\u20131250","journal-title":"Tumour Biol"},{"key":"687_CR32","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","volume":"128","author":"J Ertle","year":"2011","unstructured":"Ertle J, Dechene A, Sowa JP, Penndorf V, Herzer K, Kaiser G, Schlaak JF, Gerken G, Syn WK, Canbay A (2011) Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 128:2436\u20132443","journal-title":"Int J Cancer"},{"key":"687_CR33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5301\/jbm.5000015","volume":"28","author":"H Yang","year":"2013","unstructured":"Yang H, Chen GD, Fang F, Liu Z, Lau SH, Zhang JF, Lau WY, Yang LY (2013) Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma. Int J Biol Markers 28:286\u2013297","journal-title":"Int J Biol Markers"},{"key":"687_CR34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12020-012-9639-6","volume":"42","author":"SS Moon","year":"2012","unstructured":"Moon SS, Lee YS, Kim SW (2012) Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 42:423\u2013429","journal-title":"Endocrine"},{"key":"687_CR35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2036.2011.04924.x","volume":"35","author":"PE Pardee","year":"2012","unstructured":"Pardee PE, Dunn W, Schwimmer JB (2012) Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther 35:248\u2013254","journal-title":"Aliment Pharmacol Ther"},{"key":"687_CR36","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.2011-3010","volume":"97","author":"M Li","year":"2012","unstructured":"Li M, Xu Y, Xu M, Ma L, Wang T, Liu Y, Dai M, Chen Y, Lu J, Liu J, Bi Y, Ning G (2012) Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab 97:2033\u20132038","journal-title":"J Clin Endocrinol Metab"},{"key":"687_CR37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00508-012-0211-4","volume":"124","author":"T Purnak","year":"2012","unstructured":"Purnak T, Beyazit Y, Ozaslan E, Efe C, Hayretci M (2012) The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. Wien Klin Wochenschr 124:526\u2013531","journal-title":"Wien Klin Wochenschr"},{"key":"687_CR38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4254\/wjh.v5.i11.627","volume":"5","author":"M Kaya","year":"2013","unstructured":"Kaya M, I\u015f\u0131k D, Be\u015fta\u015f R, Evliyao\u011flu O, Akpolat V, B\u00fcy\u00fckbayram H, Kaplan MA (2013) Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J Hepatol 5:627\u2013634","journal-title":"World J Hepatol"},{"key":"687_CR39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00198-010-1525-6","volume":"23","author":"SA Polyzos","year":"2012","unstructured":"Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, Terpos E (2012) Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women\u2014the six-month effect of risedronate and teriparatide. Osteoporos Int 23:1171\u20131176","journal-title":"Osteoporos Int"},{"key":"687_CR40","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1210\/jc.2014-2327","volume":"99","author":"J Paccou","year":"2014","unstructured":"Paccou J, Mentaverri R, Renard C, Liabeuf S, Fardellone P, Massy ZA, Brazier M, Kamel S (2014) The relationships between serum sclerostin, bone mineral density and vascular calcification in rheumatoid arthritis. J Clin Endocrinol Metab 99:4740\u20134748","journal-title":"J Clin Endocrinol Metab"},{"key":"687_CR41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0032-1312618","volume":"44","author":"E Voskaridou","year":"2012","unstructured":"Voskaridou E, Christoulas D, Plata E, Bratengeier C, Anastasilakis AD, Komninaka V, Kaliontzi D, Gkotzamanidou M, Polyzos SA, Dimopoulou M, Terpos E (2012) High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density. Horm Metab Res 44:909\u2013913","journal-title":"Horm Metab Res"},{"key":"687_CR42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12020-012-9748-2","volume":"42","author":"G Musso","year":"2012","unstructured":"Musso G (2012) Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block. Endocrine 42:237\u2013239","journal-title":"Endocrine"}],"container-title":"Journal of Bone and Mineral Metabolism","original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-015-0687-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0687-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T16:29:23Z","timestamp":1566836963000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,9]]},"references-count":42,"journal-issue":{"published-print":{"date-parts":[[2016,7]]},"issue":"4"},"alternative-id":["687"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00774-015-0687-x","relation":{"cites":[]},"ISSN":["0914-8779","1435-5604"],"subject":["Endocrinology, Diabetes and Metabolism","Endocrinology","Orthopedics and Sports Medicine","General Medicine"],"container-title-short":"J Bone Miner Metab"}